Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors | The Review of Diabetic Studies
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials - The Lancet Diabetes & Endocrinology
Diabetes mellitus Typ 1: Add-on-Therapie zu Insulin im Blick
GLP-1: Actions on Beta-cell Mass and Function
GLP-1 Agonists in Type 1 Diabetes Mellitus | Semantic Scholar
View of Alpha cell function in type 1 diabetes | British Journal of Diabetes
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes: Molecular Therapy
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes | Nature Reviews Nephrology
Glucagon-like Peptide (GLP-1) and the treatment of diabetes - YouTube
GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet? - The Lancet Diabetes & Endocrinology
Clinical Trial Tests Efficacy of Short-Acting GLP-1 Receptor Agonist in Type 1 Diabetes
Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial - Endocrine Practice
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus
GLP-1R and Diabetes
How Does GLP-1 Affect Diabetes?
Use of GLP-1 Receptor Agonists Scarce in Type 2 Diabetes | MedPage Today
Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control | Hypertension
Obesity In Patients With Type 1 Diabetes - DMSO | DMSO
GLP-1 receptor agonists and type 1 diabetes - DiabetesontheNet
In type 1 patients with residual ß-cell function, GLP-1 treatment... | Download Scientific Diagram
GLP-1 Agonist Effects on Glucagon Suppression
Glucagon-like peptide-1 - Wikipedia
Mini‐review: Glucagon responses in type 1 diabetes – a matter of complexity - Bisgaard Bengtsen - 2021 - Physiological Reports - Wiley Online Library
2 Medikamentöse Therapie des Glukosestoffwechsels — Leitlinien.de
Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes - ScienceDirect
Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes, the ADJUNCT ONE™ treat-to-target randomised trial - Media Centre | EASD
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
